| Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY … KK Ray, HM Colhoun, M Szarek, M Baccara-Dinet, DL Bhatt, VA Bittner, ... The lancet Diabetes & endocrinology 7 (8), 618-628, 2019 | 248 | 2019 |
| Relation of lipoprotein (a) levels to incident type 2 diabetes and modification by alirocumab treatment GG Schwartz, M Szarek, VA Bittner, DL Bhatt, R Diaz, SG Goodman, ... Diabetes Care 44 (5), 1219-1227, 2021 | 22 | 2021 |
| Removal of the tumor thrombus from the right atrium without extracorporeal circulation: Emphasis on the displacement of the tumor apex DV Shchukin, VN Lesovoy, GG Khareba, AI Harahatyi, AV Maltsev, ... Advances in urology 2020, 2020 | 7 | 2020 |
| PROGNOSTICATION OF CLINICAL OUTCOMES AFTER STEMI: THE ROLE OF VASCULAR ENDOTHELIAL GROWTH FACTOR-A. O Petyunina, M Kopytsya, I Kuznetsov, I Vyshnevska Georgian medical news, 79-86, 2018 | 6 | 2018 |
| The vascular endothelial growth factor-A gene polymorphism predicts clinical outcomes among acute ST-segment elevation myocardial infarction patient IM Kutia, MP Kopytsya, YV Hilova, OV Petyunina, AE Berezin | 5 | 2020 |
| Biomarker-based prognostication of adverse cardiac remodeling after STEMI: the role of single nucleotide polymorphism T786C in endothelial NO-synthase gene OV Petyunina, MP Kopytsya, AE Berezin Journal of Cardiology and Therapy 6 (1), 768-774, 2019 | 5 | 2019 |
| Promising Role of Vascular Endothelial Growth Factor-A in Risk Stratification after PCI OV Petyunina, MP Kopytsya, IS Rudyk, GS Isayeva Vascular Access Surgery-Tips and Tricks, 2019 | 4 | 2019 |
| Macrophage inhibitory factor predicted late cardiac remodeling in acute myocardial infarction patients underwent successful percutaneous coronary intervention OV Petyunina, MP Kopytsya, AE Berezin La Prensa Medica Argentina 105 (5), 160-169, 2019 | 4 | 2019 |
| Lower circulating cell-free mitochondrial DNA is associated with heart failure in type 2 diabetes mellitus patients TA Berezina, MP Kopytsya, OV Petyunina, AA Berezin, Z Obradovic, ... Cardiogenetics 13 (1), 15-30, 2023 | 3 | 2023 |
| Biomarker SST2 as an early predictor of acute renal injury in patients with ST-segment elevation acute myocardial infarction. I Vyshnevska, M Kopytsya, Y Hilоva, E Protsenko, O Petyunina Georgian Medical News, 53-58, 2020 | 3 | 2020 |
| Features of the cardiovascular system lesion in patients with COVID-19 M Kopytsya, I Rodionova, N Tytarenko, Y Hilyova, I Kutya, A Kobets ScienceRise: Medical Science, 4-12, 2020 | 3 | 2020 |
| Short-term clinical outcomes in patients with acute myocardial infarction after successful percutaneous coronary revascularization: the role of promoter polymorphism of the … OV Petyunina, MP Kopytsya, DP Babichev, AE Berezin Biomedical Research and Therapy 6 (5), 3166-3179, 2019 | 3 | 2019 |
| Elevated levels of circulating soluble ST2 at discharge predict late adverse ventricular remodeling in patients with ST-segment elevation myocardial infarction OV Petyunina, MP Kopytsya, AE Berezin Biomedical Research and Therapy 5 (12), 2863-2875, 2018 | 3 | 2018 |
| GROWTH DIFFERENTIATION FACTOR 15 AS A PROGNOSTIC MARKER OF CHRONIC HEART FAILURE PROGRESSION IN LONG-TERM FOLLOW-UP AFTER ACUTE CORONARY SYNDROME. M Kopytsya, I Vyshnevska, O Protsenko, H Barahmeh Georgian Medical News, 61-66, 2017 | 3 | 2017 |
| Macrophage migration inhibitory factor levels predict no-reflow in ST-segment elevation myocardial infarction TY Storozhenko, IR Vishnevskaya, MP Kopytsya, AE Berezin | 2 | 2021 |
| The role of growth differentiation factor 15 as a predictor of 5-year survival of patients after acute coronary syndrome. IR Vyshnevska, MP Kopytsya, IM Kutya, OS Protsenko Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 48 (287 …, 2020 | 2 | 2020 |
| Особенности поражения сердечно-сосудистой системы при COVID-19 M Kopytsya, I Rodionova, N Tytarenko, Y Hilova, I Kutya, A Kobets ScienceRise: Medical Science, 4-12, 2020 | 2 | 2020 |
| The role of Val66Met single nucleotide polymorphism in brain-derived neurotropic factor gene in prediction of adverse outcomes after ST-segment elevation myocardial infarction OV Petyunina, MP Kopytsya, AE Berezin, OV Skrynnyk Heart and Mind 3 (1), 7-14, 2019 | 2 | 2019 |
| Васкулоендотеліальний фактор росту А та поліморфізм G634C гена ВЕФР-A у хворих інфарктом міокарда в гострий та віддалений періоди МП Копиця, ІМ Кутя, ЮВ Родіонова World science 2 (8 (36)), 11-17, 2018 | 2 | 2018 |
| Comparative analysis of oncologic outcomes of radical nephrectomy and nephron-sparing surgery in patients with intravenous extension of tumor into the renal vein DV Shchukin, VN Lesovoy, IA Garagatiy, GG Khareba, VI Savenkov, ... New Armenian Medical Journal 11 (2), 58-62, 2017 | 2 | 2017 |
